Tocilizumab attenuates acute lung and kidney injuries and improves survival in a rat model of sepsis via down-regulation of NF-κB/JNK: a possible role of P-glycoprotein
Abstract
Acute lung injury (ALI) and acute kidney injury (AKI) are major causes of sepsis-induced mortality. The objective of the study is to evaluate the effect of tocilizumab (TCZ), an IL-6 receptor inhibitor, in sepsis-induced ALI and AKI using the cecal ligation and puncture (CLP) rat model of sepsis. Clinical and experimental studies have demonstrated the importance of IL-6 in sepsis; however, the role of TCZ has not been investigated. Rats subjected to CLP developed histological evidence of ALI and AKI at 24 h. We found that TCZ alleviated sepsis-induced ALI and AKI as evidenced by improvements in various pathological changes, a significant reduction in the lung wet/dry weight ratio and total protein content in bronchoalveolar lavage fluid (BALF), and a significant decrease in the elevated serum level of creatinine (CR) and blood urea nitrogen (BUN). TCZ induced an increase in the survival rate of treated rats. Additionally, TCZ markedly inhibited sepsis-induced pulmonary and renal inflammatory responses. Moreover, we found that treatment with TCZ inhibited oxidative stress and apoptosis in lung and kidney tissue. TCZ treatment significantly inhibited NF-κB activation, attenuating JNK signaling pathway and significantly up-regulated P-glycoprotein (P-gp) expression in pulmonary as well as in renal tissues. Our data provide novel evidence that TCZ has a protective effect against sepsis-induced ALI and AKI by blocking IL-6 receptor signaling. This could provide a molecular basis f…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
ARDS and renal dysfunction induced in a sepsis rat model are suppressed by anti-IL-6R antibody through the suppression of NF-κB activation.
“Furthermore, it has been shown that ARDS and renal dysfunction induced in a sepsis rat model are suppressed by anti-IL-6R antibody through the suppression of NF-κB activation (356).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [356]
Cites
The immunopathogenesis of sepsis
Cohen, J. (2002) · Nature · doi:10.1038/nature01326 · Cited by 2,742 · see citing works
Rigoulet, M., Yoboue, E. D., & Devin, A. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3363 · Cited by 394 · see citing works
IL-6 Induces NF-κB Activation in the Intestinal Epithelia
Wang, L., Walia, B., Evans, J., Gewirtz, A. T., Merlin, D., & Sitaraman, S. V. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3194 · Cited by 243 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
McGonagle, D., Sharif, K., O'Regan, A., & Bridgewood, C. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102537 · Cited by 1,654 · see citing works
“• Reduced sepsis-induced pulmonary and renal inflammatory • Decreased mortality [72] D.”
BackgroundIL-6 in inflammation, autoimmunity and cancer
Hirano, T. (2021) · International Immunology · doi:10.1093/intimm/dxaa078 · Cited by 1,453 · see citing works
Systemic Inflammatory Response Syndrome After Surgery: Mechanisms and Protection
Margraf, A., Ludwig, N., Zarbock, A., & Rossaint, J. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005175 · Cited by 304 · see citing works
Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review
Cortegiani, A., Ippolito, M., Greco, M., Granone, V., Protti, A., Gregoretti, C., Giarratano, A., Einav, S., & Cecconi, M. (2020) · Pulmonology · doi:10.1016/j.pulmoe.2020.07.003 · Cited by 176 · see citing works
Miao, Z.-R., Miao, Z.-Y., Wang, S.-C., Wu, H., & Xu, S.-W. (2021) · Fish and Shellfish Immunology · doi:10.1016/j.fsi.2021.12.017 · Cited by 144 · see citing works
The role of IL-6 in coronavirus, especially in COVID-19
Wang, X., Tang, G., Liu, Y., Zhang, L., Chen, B., Han, Y., Fu, Z.-Y., Wang, L., Hu, G.-Z., Ma, Q., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1033674 · Cited by 82 · see citing works
“Tocilizumab’s effect has also been recorded in CRS linked with sepsis, graft-versus-host disease (GvHD) and macrophage activation syndrome (MAS), among others (Barut et al., 2017; Ibrahim et al., 2020; Melgarejo-Ortuno et al., 2021).”
BackgroundXu, Z., Yang, S., Tan, Y., Zhang, Q., Wang, H., Tao, J., Liu, Q., Wang, Q., Feng, W., Li, Z., et al. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05379-9 · Cited by 57 · see citing works
“These effects collectively alleviate sepsis-induced acute kidney injury (AKI) and improve survival rates in rats [341].”
IL-6 and diabetic kidney disease
Zhang, L., Xu, F., & Hou, L.-Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1465625 · Cited by 50 · see citing works
Abdelnaser, M., Alaaeldin, R., Attya, M., & Fathy, M. (2023) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-023-02650-y · Cited by 41 · see citing works
NK cell-derived IL-10 supports host survival during sepsis
Jensen, I. J., McGonagill, P. W., Butler, N., Harty, J., Griffith, T. S., & Badovinac, V. (2021) · Journal of Immunology · doi:10.4049/jimmunol.2001131 · Cited by 38 · see citing works
Regulation of P-Glycoprotein during Oxidative Stress
Shchulkin, A. V., Abalenikhina, Y. V., Kosmachevskaya, O. V., Topunov, A. F., & Yakusheva, E. N. (2024) · Antioxidants · doi:10.3390/antiox13020215 · Cited by 38 · see citing works
Senousy, S., Ahmed, A.-S. F., Abdelhafeez, D. A., Khalifa, M., Abourehab, M. A. S., & El-Daly, M. (2022) · Drug Design, Development and Therapy · doi:10.2147/dddt.s370460 · Cited by 29 · see citing works
“Induction of Sepsis by CLP Polymicrobial sepsis was induced surgically by CLP operation, as described previously.(30,31) A severe model was performed through the ligation of more than 75% of the cecum (nearly below the ileo-cecal valve) and puncturing twice with an 18-gauge needle.”
MethodSelf-citationLiu, K., Tian, L., Tang, X., Wang, J., Tang, W.-Q., Ma, Z.-H., Chen, T., & Liang, H.-P. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155001 · Cited by 29 · see citing works
Immunotherapy in the context of sepsis-induced immunological dysregulation
Wu, Y.-Q., Wang, L., Li, Y., Cao, Y., Wang, M., Deng, Z.-H., & Kang, H.-J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1391395 · Cited by 27 · see citing works
Shan, R.-R., Yu, J.-T., Zhang, S.-F., Xie, M.-M., Hou, R., Xie, C.-Y., Dong, Z.-H., Yang, Q., Hu, X.-W., Dong, Y.-H., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155252 · Cited by 27 · see citing works
Matouk, A., El-Daly, M., Habib, H. A., Senousy, S., Hafez, S. M. N. A., Kasem, A. W., Almalki, W., Alzahrani, A., Alshehri, A., & Ahmed, A.-S. F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.952337 · Cited by 27 · see citing works
Self-citationLi, T., Ji, X.-J., Liu, J.-F., Guo, X., Pang, R., Zhuang, H.-Z., Dong, L., Duan, M.-L., & Li, A. (2022) · Kidney & Blood Pressure Research · doi:10.1159/000521648 · Cited by 27
Ni, S.-Y., Xu, W.-T., Liao, G.-Y., Wang, Y., & Li, J. (2021) · Inflammation · doi:10.1007/s10753-021-01431-0 · Cited by 27
The unleashing of the immune system in COVID-19 and sepsis: the calm before the storm?
Bellinvia, S., Edwards, C., Schisano, M., Banfi, P., Fallico, M., & Murabito, P. (2020) · Inflammation Research · doi:10.1007/s00011-020-01366-6 · Cited by 27 · see citing works
Fadanni, G. P., & Calixto, J. Β. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.07.002 · Cited by 27 · see citing works
Inflammatory stress in SARS-COV-2 associated Acute Kidney Injury
Chen, J., Wang, W., Tang, Y., Huang, X., Yu, X., & Lan, H.-Y. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.58791 · Cited by 35 · see citing works
“TCZ has been shown to block the IL-6/NF-κB/JNK pathway to have a protective effect against sepsis-induced acute lung injury and AKI [158].”
BackgroundWang, Y., Deng, F., Zhong, X., Du, Y.-J., Fan, X.-Y., Su, H., & Pan, T.-R. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175730 · Cited by 25 · see citing works
Al-Kadi, A., El-Daly, M., El-Tahawy, N., Khalifa, M., & Ahmed, A.-S. F. (2021) · Fundamental & Clinical Pharmacology · doi:10.1111/fcp.12718 · Cited by 25
“Oxidative stress has been shown to contribute to sepsis-induced AKI after CLP [18].”
BackgroundMethodSelf-citationYu, Y., Li, X.-Q., Hu, W., Cu, S., Dai, J.-J., Gao, Y.-N., Zhang, Y., Bai, X., & Shi, D.-Y. (2021) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.22541/au.162437247.76584564/v1 · Cited by 25
Zisman, D., Safieh, M., Simanovich, E., Feld, J., Kinarty, A., Zisman, L., Gazitt, T., Haddad, A., Elias, M., Rosner, I., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.739592 · Cited by 25 · see citing works
“This assumption is corroborated by the cooperation between TNFα-induced NF-κB and the JAK/STAT3 pathway which has recently been demonstrated in brain pericytes [41], and by the inhibitory effects of TCZ on NF-κB in a rat model of sepsis [42].”
BackgroundAn, A. Y., Baghela, A., Zhang, P., Falsafi, R., Lee, A. H., Trahtemberg, U., Baker, A., dos Santos, C. D., & Hancock, R. W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1167917 · Cited by 21 · see citing works
Ji, Y., Zhao, Z., Yang, Y., Wang, X., Qiao, R., Yu, X., Gong, X., Feng, Z. C., & Hong, Q. (2025) · Research · doi:10.34133/research.0738 · Cited by 12 · see citing works
“…targeting the IL-6 receptor tocilizumab (TCZ) not only exerts protective effects in sepsis-induced AKI and improves patient survival rates [ 201 ] but also delays cellular senescence in rhabdomyolysis-associated AKI by inhibiting the IL-6/GATA2/SERPINE1 pathway and down-regulates the mRNA…”
Zhao, Q., Zhang, R., Wang, Y., Li, T., Xue, J., & Chen, Z. (2024) · Biochimica et Biophysica Acta - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167331 · Cited by 20
Al-Kadi, A., Ahmed, A.-S. F., El-Tahawy, N., Khalifa, M., & El-Daly, M. (2020) · Journal of advanced Biomedical and Pharmaceutical Sciences · doi:10.21608/jabps.2020.37074.1091 · Cited by 17 · see citing works
“During or after experimental induction of sepsis, TNF-α and IL-6 are released from monocytes and endothelial cells; which causes free radical formation and oxidative tissue injury [62-64].”
BackgroundSelf-citationYe, S.-Y., Ma, L., Chi, Y.-N., Liu, N., Liu, Y., Wei, W., Niu, Y., Zheng, P., Yu, J.-Q., & Hai, D. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156664 · Cited by 16 · see citing works
Lee, C., Nguyen, A. T., Doan, L. H., Chu, L.-W., Chang, C.-H., Liu, H., Lee, I.-L., Wang, T.-H., Lai, J.-M., Tsao, S., et al. (2023) · Viruses · doi:10.3390/v15030641 · Cited by 16 · see citing works
“Inhibition of NF-κB/JNK would be effective against sepsis-induced acute lung injury [59].”
Li, H., Zhang, W., Lou, Q., Chang, Y., Lin, Z., & Lou, L. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/6248870 · Cited by 8 · see citing works
“NF-κB, a key regulator of cellular inflammation balance, has emerged as an important therapeutic target for various diseases, and the inhibition of NF-κB can alleviate the ALI [44, 45].”
BackgroundSarıoğlu, N., Sunay, F., Yay, A., Korkut, O., Erel, F., Hişmioğullari, A., Köse, M., & Yalçın, B. (2021) · Turkish Journal of Medical Sciences · doi:10.3906/sag-2010-303 · Cited by 15 · see citing works
“Some experimental studies indicate that tocilizumab has a protective effect against acute 28 lung injury [25,26].”
BackgroundSenousy, S., El-Daly, M., Ibrahim, A., Khalifa, M., & Ahmed, A.-S. F. (2022) · Biomedicines · doi:10.3390/biomedicines10071613 · Cited by 14 · see citing works
“Citation: Senousy, S.R.; El-Daly, M.; Ibrahim, A.R.N.; Khalifa, M.M.A.; Ahmed, A.-S.F. Effect of Celecoxib and Infliximab against Multiple Organ Damage Induced by Sepsis in Rats: A Comparative Study.”
BackgroundInfluentialSelf-citationWang, X., Zhang, X.-X., Sun, L., Gao, G.-S., & Li, Y. (2022) · European Journal of Medical Research · doi:10.1186/s40001-022-00845-2 · Cited by 13 · see citing works
Fujita, K., Takata, I., Yoshida, I., Takashima, H., & Sugiyama, H. (2022) · Journal of antibiotics (Tokyo. 1968) · doi:10.1038/s41429-021-00498-z · Cited by 13
“Some studies were reported that mice or rats treated with anti-IL-6 antibody showed prolonged survival in the cecum ligation and puncture-induced sepsis model [31, 32].”
BackgroundMethodRecent Updates in Experimental Research and Clinical Evaluation on Drugs for COVID-19 Treatment
Zou, H., Yang, Y., Dai, H.-L., Xiong, Y.-C., Wang, J.-Q., Lin, L., & Chen, Z.-S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.732403 · Cited by 13 · see citing works
“For the mechanism of action, TCZ specially binds membrane-bound interleukin-6 receptor (mIL-6R) and soluble interleukin-6 receptor (sIL-6R) and inhibits signal transduction (Ibrahim et al., 2020).”
BackgroundTocilizumab is effective in preventing ovarian injury induced by ischemia- reperfusion in rats.
Uzel, K., Lakhno, I. V., Turkler, C., Kuzucu, M., Yazici, G., Mammadov, R., Suleyman, B., Kale, A., & Suleyman, H. (2023) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202320220442 · Cited by 12 · see citing works
Morsy, M., El-Daly, M., Kamel, B., Rifaai, R., & Abdel-Gaber, S. (2023) · European Review for Medical and Pharmacological Sciences · doi:10.26355/eurrev_202305_32484 · Cited by 12
Piccirillo, M., Ascierto, P., Atripaldi, L., Cascella, M., Costantini, M., Dolci, G., Facciolongo, N., Fraganza, F., Marata, A., Massari, M., et al. (2020) · Contemporary Clinical Trials · doi:10.1016/j.cct.2020.106165 · Cited by 12 · see citing works
Wang, B., Wang, Q., Liang, Z., Yin, Y., Wang, L., Wang, Q., Li, Y., Ou, J., Ren, H., & Dong, Y. (2023) · Annals of Hematology · doi:10.1007/s00277-023-05146-0 · Cited by 13 · see citing works
Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era
Gandini, L., Fior, G., Schibler, A., Obonyo, N. G., Bassi, G. L., Suen, J. Y., & Fraser, J. F. (2023) · Critical Care · doi:10.1186/s13054-023-04394-w · Cited by 12 · see citing works
“In two studies [4, 5], a parallel safety trial was conducted with higher doses of tocilizumab (up to 64 mg/kg), and no adverse effect was observed.”
BackgroundWang, H., Peng, X., Huang, Y., Xiao, Y., Wang, Z., & Zhan, L. (2019) · Yonsei Medical Journal · doi:10.3349/ymj.2019.60.12.1195 · Cited by 11 · see citing works
“JNK is closely related to inflammation, cell apoptosis, and autophagy,(8) and excessive activation of JNK has been implicated in nephropathy and renal I/R injury.(9,10) Accordingly, we hypothesized that propofol could attenuate hypoxia/reoxygenation-induced apoptosis and autophagy in human renal proximal tubular cells…”
BackgroundAhmed, A.-S. F., Bayoumi, A. M. A., Eltahir, H. M., Hafez, S. A. A., & Abouzied, M. (2020) · doi:10.21608/jabps.2019.19876.1061 · Cited by 10
“The severe pulmonary inflammation, vascular permeability, diffuse inter-alveolar septa, inflammatory cells and oedema within the lungs were detected in septicaemia (CLP group) consistent with previous findings [36].”
ResultSelf-citationIbrahim, Y. F., Hammady, S. H., Rifaai, R., Waz, S., Ibrahim, M., & Hafez, H. M. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110139 · Cited by 9
Self-citationAcute kidney injury in COVID 19 – an update on pathophysiology and management modalities
Khokhar, M., Purohit, P., Roy, D., Tomo, S., Gadwal, A., Modi, A., Banerjee, M., & Sharma, P. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1856141 · Cited by 9 · see citing works
“Tocilizumab inhibits sepsis-induced inflammatory response in AKI, possibly through upregulated P-glycoprotein in kidney tissue (Ibrahim et al. 2020, Luo et al. 2020a).”
BackgroundFüll, Y., Schüssele, L. M., Hamza, H., Hoffmann, H., Bauer, M., Stenglein, S., Pötz, O., Steinhilber, A., Anselm, V., Delany, M., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1631721 · Cited by 8 · see citing works
“Brie fl y, 50 ml whole blood (roughly 5x10 7 PBMCs) of two donors were taken in 50 ml syringes (BD Biosciences, Franklin Lakes, New Jersey, USA) supplied with heparin-natrium (100.000 I.E./ml; Braun, Melsungen, Germany).”
InfluentialDai, J.-M., Zhang, X.-Q., Zhang, J.-J., Yang, W.-J., Yang, X.-M., Bian, H., & Chen, Z.-N. (2022) · MedComm · doi:10.1002/mco2.132 · Cited by 8 · see citing works
Hasselbach, L., Weidner, J., Elsässer, A., & Theilmeier, G. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.809935 · Cited by 8 · see citing works
Alazouny, Z. M., Alghonamy, N. M., Mohamed, S., & Aal, S. M. A. (2022) · Ultrastructural Pathology · doi:10.1080/01913123.2022.2039826 · Cited by 7 · see citing works
“as well as the maintenance of macrophage and monocyte functions.(8,9)”
BackgroundTocilizumab for severe COVID‐19 pneumonia: Case series of 5 Australian patients
West, T. A., Malik, S., Nalpantidis, A., Tran, T., Cannon, C., Bhonagiri, D., Chan, K., Cheong, E., Cheong, J. W. S., Cheung, W., et al. (2020) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13913 · Cited by 7 · see citing works
Casein Kinase 2 Alpha Inhibition Protects against Sepsis-Induced Acute Kidney Injury
Koo, J.-H., Yu, H. C., Nam, S., Kim, D.-C., & Lee, J.-H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129783 · Cited by 5
Cytokines in sepsis: friend or enemy?
Senousy, S., Ahmed, A.-S. F., El-Daly, M., & Khalifa, M. (2021) · Journal of advanced Biomedical and Pharmaceutical Sciences · doi:10.21608/jabps.2021.93867.1138 · Cited by 5 · see citing works
“NF-κB activation and attenuation of JNK signaling pathway [117].”
BackgroundSelf-citationAljuhani, O. A., Sulaiman, K. A. A., Korayem, G. B., Alharbi, A. A., Altebainawi, A. F., Aldkheel, S. A., Alotaibi, S. G., Vishwakarma, R. K., Alshareef, H. M., Alsohimi, S., et al. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2268213 · Cited by 6 · see citing works
“In addition, TCZ was associated with a nephroprotective effect in an animal model of sepsis-induced AKI, evidenced by improvements in various of pathological changes and a decrease in the serum creatinine and blood urea nitrogen [25].”
BackgroundAnti-inflammatory Effect of Low-Intensity Ultrasound in Septic Rats.
Tang, W., Xia, Y., Deng, J., Xu, H., Tang, Y., Xiao, X., Wu, L., Song, G.-L., Qin, J., & Wang, Y. (2023) · Ultrasound in Medicine and Biology · doi:10.1016/j.ultrasmedbio.2023.03.008 · Cited by 4
Klotho modulation by tempol: a potential therapeutic axis in sepsis
Al-Kadi, A., Anter, A., Rofaeil, R., Sayed-Ahmed, M. M., Hafez, S. A. A., & Ahmed, A.-S. F. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04738-0 · Cited by 3
Self-citationFuture Directions in Therapies for Acute Respiratory Distress Syndrome.
Millar, J. E., Reddy, K., & Bos, L. (2024) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2024.08.014 · Cited by 3
Expression of FoxO3a in sepsis mice and its association with lymphocyte apoptosis.
Wen, Y., Li, Y., Guo, J.-L., & Shang, K. (2024) · Cellular and Molecular Biology · doi:10.14715/cmb/2024.70.5.37 · Cited by 3
“Apoptosis of a large number of immune cells and non-immune cells during the occurrence and development of sepsis is a key factor causing death in sepsis patients [10].”
BackgroundNatural products for treating cytokine storm-related diseases: Therapeutic effects and mechanisms.
Liu, M., Wang, Q., Xu, W., Wu, J., Xu, X., Yang, H., & Li, X. (2023) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2023.115555 · Cited by 3 · see citing works
Alzokaky, A. A., Saber, S. K., & Zaki, M. O. (2025) · Food and Chemical Toxicology · doi:10.1016/j.fct.2025.115439 · Cited by 2 · see citing works
Hu, Y., Jiang, Y.-W., Liu, S., Shen, J.-W., & An, Y. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s338914 · Cited by 2
The RIPK3-IL-6 axis mediates kidney injury in cytokine storm syndrome
Guerrero-Mauvecin, J., Martín-Sanchez, D., Villar-Gómez, N., Carrasco, S., Chinchilla, B., Carriazo, S., Martínez-Moreno, J., Miño-Izquierdo, L., Gómez, M. J., Sanchez-Niño, M., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08686-1 · Cited by 1
Martins, A. A., Lima, M. L. D. S., Vieira, G. H. A., Costa, H. E. S., Leitão, R. C., Ribeiro, S. B., Medeiros, C., Silva, D. N. A., Suksakulchai, R., Pirih, F., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-30737-4 · Cited by 1
“In contrast to systemic administration 29,30 , the local application maintains average plasma concentrations of these markers, indicating a lack of adverse effects on the liver and kidneys.”
Kidneys in SARS‐CoV‐2 era: A challenge of multiple faces
Abdelsalam, M., Wahab, A. M. A. E., Nassar, M., Samaan, E., Eldeep, A., Abdalbary, M., Tawfik, M., Saleh, M., Shemies, R., & Sabry, A. (2022) · Therapeutic apheresis and dialysis · doi:10.1111/1744-9987.13792 · Cited by 1
Treatment of SARS-CoV-2 (COVID-19): A safety perspective
Davis, J. A., Umeh, U., & Saba, R. (2021) · World Journal of Pharmacology · doi:10.5497/wjp.v10.i1.1 · Cited by 1 · see citing works
Aarskog, N. R., Aass, H., Holter, J., Rostrup, M., & Holten, A. R. (2021) · Critical Care Explorations · doi:10.1097/cce.0000000000000542 · Cited by 1
“In this condition, there may be a biological rationale for blocking systemic IL-6, as has recently been demonstrated in a rat sepsis model (8).”
BackgroundSepsis Oluşturmak için Kullanılan Deneysel Hayvan Modelleri
Erkayman, B. (2020) · Atatürk Üniversitesi Veteriner Bilimleri Dergisi · doi:10.17094/ataunivbd.690314 · Cited by 1
“yöntemi kullanılarak yapılan birçok bilimsel çalışma literatürde mevcuttur (22-24).”
Shen, Y.-Q., Tai, Y., Liu, X.-Z., Li, Y., Zhao, Z.-H., Jin, X.-J., & Ma, J. (2026) · Cells · doi:10.3390/cells15171574
“Tocilizumab has also shown similar lung-protective effects in a CLP-induced sepsis model [161].”
Erol, H. S., Demirci, B., Alhilal, M., Terzi, F., & Kelercioglu, N. (2026) · Journal of biochemical and molecular toxicology · doi:10.1002/jbt.70947
Li, X., Zhang, J., Feng, Y.-H., Zhou, Q.-H., & Zhang, C.-L. (2026) · Respiratory Research · doi:10.1186/s12931-025-03458-5
“Both TCZ and corticosteroids alleviate acute lung injury and diminish airway inflammation by modulating the NF-κB signaling pathway [54, 55].”
Yao, Q., Yao, Y., Liao, Z., Wang, J., & Yu, M. (2026) · Clinical and applied thrombosis/hemostasis · doi:10.1177/10760296261438237
Obakanurhe, O. (2024) · Archives of Veterinary Science · doi:10.5380/avs.v29i3.95892
Effect of genetically engineered drugs in aseptic necrosis of the femoral head in rats
Shabaldin, N., Sinitskaya, A., Igisheva, L. N., Bogdanov, L., & Shabaldin, A. (2024) · Российский физиологический журнал им И М Сеченова · doi:10.31857/s0869813924020022
Effect of Genetically Engineered Drugs on Aseptic Femoral Head Necrosis in Rats
Shabaldin, N., Sinitskaya, A., Igisheva, L. N., Bogdanov, L., & Shabaldin, A. (2024) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093024010253
“The doses of therapeutic monoclonal blockers of pro-inflammatory cytokines, used in this study, were also applied in the model experiments on small animals to explore their effects on pathological processes [20, 21].”
Browning, B., Couenne, F., Bordes, C., Fayolle, L., Venet, F., Textoris, J., Monneret, G., & Tayakout-Fayolle, M. (2023) · bioRxiv · doi:10.1101/2023.02.14.527104
Important role of long non-coding RNA UBE2R2-AS1 in diabetes-induced renal injury
Chen, C., Yan, Y.-W., Luo, Q.-J., & Li, S. (2020) · Archives of medical science : AMS · doi:10.5114/aoms.2020.100649
“NF-κ B is a transcription regulator that widely exists in various tissues and cells and regulates the expression of cytokines and inflamma-tion-mediated genes, and also participates in the progress of various kidney injuries such as diabetic nephropathy [25–27].”
- Authors
- Ibrahim, Y. F., Moussa, R. A., Bayoumi, A. M. A., & Ahmed, A.-S. F.
- Affiliations
- Minia University (EG)
- Corresponding author
- Ahmed, Al-Shaimaa F.
- Venue
- Inflammopharmacology
- Published
- 2019-08-22
- Volume
- 28
- Issue
- 1
- Pages
- 215-230
- ISSN
- 0925-4692 (ISSN-L)
- 1568-5608
- OpenAlex
- W2969893880
- Cited by
- 75
- References
- 77
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 8 · 2023: 15 · 2022: 14 · 2021: 12 · 2020: 10 · 2019: 2
- FWCI
- 7.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Inflammopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- tocilizumab, sepsis, acute lung injury, acute kidney injury, IL-6 receptor inhibition, NF-κB signaling, JNK signaling, P-glycoprotein, oxidative stress, apoptosis, cecal ligation and puncture, renal inflammation, lung inflammation, survival
- MeSH terms
- Animals, Female, Kidney, Lung, Signal Transduction, Down-Regulation, NF-kappa B, Rats, Wistar, Sepsis, ATP Binding Cassette Transporter, Subfamily B, Member 1, MAP Kinase Signaling System, Rats, Acute Lung Injury, Acute Kidney Injury, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review